Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | PRKCA | P17252 | 1/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14700404 | 0.94 | PKM (0.41) | PKMPRKCAHSD11B1ALDH1A1MEN1 | |
| SCHEMBL14700531 | 0.93 | PRKCA (0.43) | PKMPRKCAHSD11B1ALDH1A1MEN1 | |
| SCHEMBL14700415 | 0.92 | ALDH1A1 (0.42) | PKMPRKCAHSD11B1ALDH1A1NPSR1 | |
| SCHEMBL14700411 | 0.91 | PKM (0.39) | PKMPRKCAHSD11B1ALDH1A1MEN1 | |
| SCHEMBL14700422 | 0.89 | PKM (0.38) | PKMPRKCAHSD11B1ALDH1A1MEN1 | |
| SCHEMBL14700427 | 0.89 | PKM (0.42) | PKMPRKCAHSD11B1 | |
| SCHEMBL14700407 | 0.89 | PKM (0.38) | PKMPRKCAHSD11B1 | |
| SCHEMBL14700557 | 0.88 | PKM (0.37) | PKMPRKCAHSD11B1 | |
| SCHEMBL14700425 | 0.86 | PKM (0.53) | PKMPRKCAALDH1A1MEN1KMT2A | |
| SCHEMBL14701500 | 0.85 | PKM (0.46) | PKMPRKCAHSD11B1ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8802352-B2 | Salt, photoresist composition and method for producing photoresist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-08-12 | — | — | US | disclosed |
| US-20130040239-A1 | SALT, PHOTORESIST COMPOSITION AND METHOD FOR PRODUCING PHOTORESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130040239-A1 | SALT, PHOTORESIST COMPOSITION AND METHOD FOR PRODUCING PHOTORESIST PATTERN | CRY1, H1-0, SPIN1 | PKM 3615/4885PRKCA 2560/4885HSD11B1 1317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.